Material named
A statute may name ibogaine while remaining silent, differently worded, or contested as to iboga root, seed, extract, or a preparation containing the substance.
Jurisdiction reference
Country Table
A sourcing-focused reference for comparing how ibogaine, iboga root and seed, extracts, and synthesized material are addressed across selected jurisdictions.
Read the status, then read the source.
Country labels are only a starting point. Classification can turn on the material involved, the statutory language in force, and whether an import, medical, research, or religious framework is separately recognized. For broader context on comparing jurisdictions, the Juravine legal overview explains the questions this table is designed to keep visible.
How to use it
One substance name can conceal several legal questions.
This table separates references to ibogaine from references to the botanical material. “Iboga” commonly refers to plants associated with Tabernanthe iboga, while legislation may instead name a chemical substance, a plant, a preparation, or a broader controlled-drugs category.
Entries use careful wording where the official text does not plainly settle every practical question. That distinction matters when looking at whether ibogaine is illegal in the United States, and it remains relevant where a statute speaks to possession but not clearly to root bark, seeds, extracts, or synthesized material.
Selected jurisdictions
Country-by-country legal status table
The entries below identify the legal framing that is commonly cited in primary or official reference material. They are not a substitute for the full text of the relevant law, implementing regulations, customs rules, or agency guidance.
| Country / jurisdiction | Classification and citation | Medical / special access | Ceremonial / religious context | Import / export and source |
|---|---|---|---|---|
| United States | Schedule I Ibogaine is listed in Schedule I under the federal Controlled Substances Act. The current DEA schedule text should be checked for the operative federal entry and wording. |
Schedule I status does not create a prescription pathway. Research handling is subject to federal controls and relevant authorizations. | No general federal ceremonial exemption is identified here for ibogaine. Religious-freedom questions depend on facts and legal context. | Import and export of controlled substances are federally regulated; do not infer permissibility from a state or local discussion.Reviewed 04 Sep 2026 |
| Canada | Controlled substance listing Ibogaine appears in Canada’s controlled-drugs framework. Confirm the applicable schedule and any amendments in the Controlled Drugs and Substances Act and its schedules. |
Any clinical, research, or access question should be read against Health Canada authorizations and current regulatory material rather than inferred from a general label. | This table does not identify a general ceremonial exemption. Separate constitutional, statutory, and enforcement questions may arise. | Controlled-drug import or export may require permits or other authority; customs treatment should be verified directly.Reviewed 04 Sep 2026 |
| Australia | Federal and state framework Legal treatment may involve Commonwealth scheduling alongside state and territory law. Check the Poisons Standard in force and the applicable local legislation. |
Any authorized pathway is jurisdiction- and regulator-specific; a table entry cannot establish prescription availability. | No general nationwide ceremonial exemption is stated here. Legal treatment can depend on the substance, conduct, and jurisdiction. | Border controls may apply independently of local possession rules. Verify import requirements before relying on any classification summary.Reviewed 04 Sep 2026 |
| New Zealand | Controlled-drug framework Consult the current schedules and definitions in the Misuse of Drugs Act 1975 rather than relying on secondary summaries. |
Medical, research, and exemption questions must be tested against the current statutory and regulatory pathway. | This entry does not establish a ceremonial or religious exemption for ibogaine or plant material. | Importation may engage controlled-drug and border rules even where material descriptions are contested.Reviewed 04 Sep 2026 |
| Mexico | Confirm current national law The treatment of ibogaine, botanical material, and preparations should be checked in current national legal and health-regulatory sources. Terminology and enforcement context can be especially important. |
This table does not identify a general prescription or special-access route. Review current authority before treating any service context as a legal conclusion. | No nationwide ceremonial exemption is asserted here. | Cross-border movement can engage Mexican rules and the laws of the destination country. Context concerning Baja ibogaine treatment is not itself proof of a legal status.Reviewed 04 Sep 2026 |
| Gabon | Botanical and cultural context Iboga has documented cultural and religious significance in Gabon, but that fact alone does not answer questions about contemporary controlled-substance classification, extracts, synthesized ibogaine, or export law. |
No medical or prescription pathway is stated here. | Ceremonial context may be relevant to local practice, but its legal scope requires current local legal verification. | Export, conservation, plant-material, and destination-country rules may all apply. Do not equate cultural use with unrestricted international movement.Reviewed 04 Sep 2026 |
Interpretive layers
Keep classification, access, and movement separate.
Pathway claimed
A research authorization, medical exemption, prescription rule, or local policy is not automatically a general permission. Questions about what an ibogaine treatment is should not be used to infer legal access.
Border rule
Import and export can be controlled independently of domestic status. The destination, transit jurisdiction, declaration rules, and permits may each matter.
Uncertainty is information
Where a record is unclear, retain the ambiguity.
Legal summaries often flatten distinctions that matter. A controlled-substance classification is not necessarily a complete answer to clinical, research, import, religious, or enforcement questions. The guide to interpreting ibogaine law sets out a practical way to read source hierarchy, dates, and statutory definitions.
For example, discussion of ibogaine treatment for addiction, ibogaine treatment for alcohol, or ibogaine for PTSD treatment does not resolve the legal classification of a substance or the authority required for a specific activity. Health and legal questions remain separate.
“A country entry is most useful when it makes clear what it does not establish.”
Source hierarchy
Primary statutes, official schedules, regulations, and regulator notices should take priority over commercial descriptions or undated summaries. The UN drug-control convention materials provide international context, but domestic legal effect depends on each jurisdiction’s own implementing law.
Scientific names and chemical terminology can also affect how a text is read. The National Library of Medicine’s PubChem record for ibogaine helps distinguish the compound name from plant and preparation terminology; it is not a statement of legal status.
Use the date beside each entry as a boundary, not as a guarantee. When a result carries practical consequences, consult the current official text or qualified counsel in the jurisdiction concerned.
Practical reading questions
Frequently asked questions
Does one country status answer every ibogaine question?
No. A legal classification may differ for iboga root or seed, extracts, and synthesized ibogaine. Import rules, prescription frameworks, enforcement practice, and ceremonial or religious questions may also be addressed separately. Terminology discussed around an ibogaine street name is not a legal definition.
How should a rapidly changing entry be read?
Use the source date and primary material linked in the table. When the wording, scope, or current status is unclear, consult official statutes, the relevant regulator, or qualified legal counsel. The source materials hub is designed to support that verification.
Does a ceremonial context create a general exemption?
Not necessarily. Cultural or religious practice and a statutory exemption are different questions. Their scope can depend on the precise substance, activity, jurisdiction, and current court or regulatory interpretation.
Why include medical or special-access columns?
They distinguish a general classification from narrow pathways that may have separate eligibility, approval, handling, or research requirements. They do not indicate availability or recommend any course of action.